OTUD7B and cancer: Together, our study provides the chemical structure for a possible OTUD7B inhibitor that can be further improved by medicinal chemistry or PROTAC/DUBTAC approaches, with potential as viable therapeutic agents in treating cancer with OTUD7B overexpression.